News
Important Only
Vaxcyte Inc reports results for the quarter ended June 30 - Earnings Summary
Vaxcyte Inc PCVX.OQ reported a quarterly adjusted loss of $1.22 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-1.10. The mean expectation of eight analysts for the quarter was for a loss of $1.17 per share. Wall Street expected r...Reuters
23 hours ago
CoreCivic (CXW) Q2 EPS Jumps 80%
Key PointsEarnings per share (non-GAAP) rose 80.0% year over year to $0.36, beating analyst expectations by a wide margin on a non-GAAP basis.Revenue (GAAP) climbed 9.8% to $538.2 million, surpassing estimates on a non-GAAP basis.Full-year 2025 guidance for all major financial metrics was increased,...The Motley Fool
23 hours ago
Gibraltar (ROCK) Q2 Revenue Rises 13%
Key PointsRevenue (GAAP) rose 13.1% from the prior year to $309.5 million but came in 18.5% below analyst expectations (non-GAAP).Adjusted earnings per share (EPS) increased 10.8% to $1.13, which missed the consensus by $0.05 (non-GAAP).Backlog in project-driven businesses surged 43% year-over-year....The Motley Fool
23 hours ago
Sana Biotechnology after launching $75 mln stock deal
** Sana Biotechnology's SANA.O shares down 16.5% after hours to $3.53 as co seeks equity raise ** Seattle, Washington-based firm commences $75 mln offering comprising stock and pre-funded warrants ** Morgan Stanley, Goldman Sachs, BofA and TD Cowen are joint bookrunners** Co, which develop...Reuters
23 hours ago
Fortrea (FTRE) Q2 Revenue Jumps 7%
Key PointsRevenue (GAAP) of $710.3 million for Q2 2025 beat analyst estimates by 12.5%, This result also marked a 7.2% increase over the second quarter of 2024.Adjusted EPS (Non-GAAP) of $0.19 for Q2 2025 exceeded expectations and Adjusted net income from continuing operations turned positive compar...The Motley Fool
23 hours ago
Chimera (CIM) Q2 EPS Misses by 15%
Key PointsEarnings available for distribution per share (non-GAAP) for Q2 2025 fell short of analyst expectations, coming in at $0.39 versus the $0.46 estimate.GAAP book value per common share was $20.91 as of June 30, 2025. Book value per common share edged down to $20.91, with a minimal economic r...The Motley Fool
23 hours ago
Fortinet forecasts third-quarter sales below estimates as trade uncertainty weighs
Aug 6 (Reuters) - Fortinet FTNT.O forecast third-quarter revenue below Wall Street estimates on Wednesday, as businesses cut back on spending amid widespread macroeconomic uncertainty stemming from global trade tensions, sending shares down 12% in extended trading. U.S. President Donald Trump's ...Reuters
23 hours ago
Choice Hotels (CHH) Q2 EBITDA Up 2%
Key PointsAdjusted EBITDA reached a Q2 2025 record of $165 million, up 2% from the prior year.Revenue (GAAP) declined 2.1% in Q2 2025 compared to the same period in 2024. Revenue came in below analyst expectations.Full-year 2025 net income and diluted EPS (GAAP) guidance was lowered, with projection...The Motley Fool
23 hours ago
US STOCKS-Wall Street ends higher with Nasdaq up more than 1%, led by Apple
Apple to announce $100-billion pledge, says White House officialS&P 500 earnings reports continue to be better than expectedIndexes: Dow up 0.2%, S&P 500 up 0.7%, Nasdaq up 1.2%By Caroline Valetkevitch NEW YORK Aug 6 (Reuters) - U.S. stocks ended higher on Wednesday, led by a more than 1%...Reuters
23 hours ago
Lyft (LYFT) Q2 Rides Jump 14% to Record
Key PointsGAAP revenue for Q2 2025 was $1.60 billion, missing analyst estimates by 0.68% (GAAP), Revenue was $1.59 billion, missing analyst estimates by 0.68%, but rising approximately 10.6% year-over-year.Record GAAP net income of $40.3 million and record free cash flow of $329.4 million, reflectin...The Motley Fool
23 hours ago
Exact Sciences (EXAS) Q2 Revenue Up 16%
Key PointsGAAP revenue reached $811 million for Q2 2025, beating consensus by 4.8% and rising 16% year-over-year.Non-GAAP EPS was $0.22 for Q2 2025.Full-year 2025 revenue and adjusted EBITDA guidance were raised, reflecting strong commercial execution and new product launches.These 10 stocks could m...The Motley Fool
23 hours ago
Novavax (NVAX) Profit Jumps on Milestone
Key PointsNovavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share.Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 million, but down 42.4% from the prior year.Results included a large one-time $175 million mi...The Motley Fool
23 hours ago
Parsons (PSN) Q2 EPS Beats by 5%
Key PointsParsons beat Non-GAAP EPS expectations with $0.78 per share in Q2 FY2025, but GAAP revenue missed consensus at $1,584 million in Q2 FY2025.Critical Infrastructure revenue grew 14%, offsetting a 19% drop in Federal Solutions revenue from lower confidential contract volume.Full-year FY2025 g...The Motley Fool
23 hours ago
Protagonist Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Protagonist Therapeutics Inc PTGX.OQ reported a quarterly adjusted loss of 55 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -50 cents. The mean expectation of twelve analysts for the quarter was for a loss of 58 cents per sh...Reuters
23 hours ago
Why Scholar Rock Stock Wilted on Wednesday
Key PointsThe company posted a relatively steep bottom-line shortfall in its second quarter.This was tempered by a business update that featured more positive news.10 stocks we like better than Scholar Rock › It didn't take a high-powered academic to figure out why Scholar Rock's (NASDAQ: SRRK) shar...The Motley Fool
23 hours ago
Avista (AVA) Q2 EPS Drops 41%
Key PointsGAAP earnings per share (EPS) and non-GAAP revenue missed analyst expectations, with EPS (GAAP) at $0.17 versus the $0.31 estimate. Electric utility margin (non-GAAP) rose 8.9% and natural gas utility margin (non-GAAP) climbed 12.8% in the second quarter of 2025 compared to the same period...The Motley Fool
23 hours ago
